ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31

ENCISION INC

Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 13, 2025

$0.01+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $163.15K
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Sep 30, 2025

Encision reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Encision's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Encision's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ECIA.

Revenue growth-3.0% · median 33.9%

Gross margin52.6% · median 52.6%

Operating margin-5.1% · median -16.2%

Net margin-6.0% · median -51.2%

Company	Revenue	Growth
SSII	$52.40M	+89.7%
UTMD	$36.11M	–
MDNC	$10.21M	-10.9%
NMTC	$9.47M	+42.8%
ECIA	$6.30M	-3.0%
LUCD	$5.45M	+24.9%

Company

Exchange: OTC
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: March 31
Employees: 24
Auditor: Green Growth CPAs
SEC CIK: 930775

Advertisement
300 × 250